The diagnosis and treatment of invasive aspergillosis in Dutch haematology units facing a rapidly increasing prevalence of azole-resistance: A nationwide survey and rationale for the DB‐MSG 002 study protocol

Alexander F. A. D. Schauwvlieghe*, Nick de Jonge, Karin van Dijk, Paul E. Verweij, Roger J. Bruggemann, Bart J. Biemond, Aldert Bart, Peter A. von dem Borne, Annelies Verbon, Martha T. van der Beek, Astrid M. P. Demandt, Guy J. Oudhuis, Jan J. Cornelissen, Walter J. F. M. van der Velden, Lambert F. R. Span, Greetje A. Kampinga, Anke H. Bruns, Alieke G. Vonk, Pieter-Jan A. Haas, Jeanette K. DoorduijnBart J. A. Rijnders

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

14 Citations (Web of Science)
Original languageEnglish
Pages (from-to)656-664
Number of pages9
JournalMycoses
Volume61
Issue number9
DOIs
Publication statusPublished - 1 Sep 2018

Keywords

  • azole-resistance
  • IFD
  • invasive aspergillosis
  • management
  • BRONCHOALVEOLAR LAVAGE FLUID
  • LIPOSOMAL AMPHOTERICIN-B
  • PLACEBO-CONTROLLED TRIAL
  • ACUTE MYELOID-LEUKEMIA
  • FUNGAL-INFECTIONS
  • FLUCONAZOLE PROPHYLAXIS
  • MOLD INFECTIONS
  • FUMIGATUS
  • POSACONAZOLE
  • DISEASE

Cite this